Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.

CONCLUSIONS mGPS at the time of recurrence might be an independent adverse prognostic factor in recurrent NSCLC. PMID: 28775246 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research